Pharmacodynamic effects of Sandostatin® in the gastrointestinal tract
- 30 September 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (9) , 17-21
- https://doi.org/10.1016/0026-0495(92)90026-7
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Distribution of somatostatin-14 and somatostatin-28 gastrointestinal-pancreatic cells of rats and humansGastroenterology, 1990
- Gastrointestinal PeptidesGastroenterology Clinics of North America, 1989
- Biochemistry and physiology of gastrointestinal somatostatinDigestive Diseases and Sciences, 1989
- Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue.Gut, 1986
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- SomatostatinNew England Journal of Medicine, 1983
- Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tractRegulatory Peptides, 1983
- Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*Journal of Clinical Endocrinology & Metabolism, 1979
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973
- Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1Endocrinology, 1968